Cargando…
2031. False-positive Serologic Results attributable to IVIG therapy
BACKGROUND: Intravenous immunoglobulin (IVIG) is used to treat an increasing number of conditions including hematologic, rheumatologic and immunodeficiency diseases. The immunomodulatory effects can be life-saving, however recent administration can complicate diagnostics when patients later present...
Autores principales: | Hanson, Kimberly E, Gabriel, Nielsen, Mchardy, Ian, Hoffmann, Wesley, Cohen, Stuart H, Welch, Ryan, Couturier, Marc Roger, Thompson, George R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253139/ http://dx.doi.org/10.1093/ofid/ofy210.1687 |
Ejemplares similares
-
Rv2031c of Mycobacterium tuberculosis: a master regulator of Rv2028–Rv2031 (HspX) operon
por: Mushtaq, Khurram, et al.
Publicado: (2015) -
Positive hepatitis B serology following IVIg treatment in a patient with mucous membrane pemphigoid
por: Colakovic, Ryan, et al.
Publicado: (2021) -
Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031
por: Nonvignon, Justice, et al.
Publicado: (2018) -
2031. Role of Urine Culture Hard Stop in Reducing Catheter-associated Urinary Tract Infections
por: Cherian, John, et al.
Publicado: (2022) -
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031
por: Abushanab, Dina, et al.
Publicado: (2023)